<DOC>
	<DOC>NCT01750437</DOC>
	<brief_summary>Randomized, double-blind, active-controlled, multi-center phase 2 clinical trial to investigate the safety, tolerability and efficacy of YH1885L in patients with non-erosive reflux disease(NERD)</brief_summary>
	<brief_title>Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>subjects who signed written informed consent form more than 20 yr subject subjects who agree the use of medically accepted birth control during trial grade N, M by EGD test subject who experience 2 day out of 1 week during recent 1 month subject who experience 2 day out of 1 week during runin period subjects who can write the diary by himself, herself pregnant woman, breastfeeding woman allgeric or intolerabiliy to revaprazan or esomeprazole feeling of heavy stomach, distention surgery history in stomach or esophagus active medical history of stomach, esophagus area other system disorder which can disturb this trial Hep B, C virus, HIV carrier or patients past history of malignant tumor any psychiatric past or current history abnormal lab test abnormal ecg test zollingerellison disease current or past history of substance, drug abuse subject who should regulary takes medication which can disturb this trial</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>NERD</keyword>
</DOC>